Safety and tolerability of a 2009 trivalent inactivated split-virion influenza vaccine in infants, children and adolescents

Influenza and other Respiratory Viruses

Volumn 7, Issue 5, 2013, Pages 676-685

  Lambert, Stephen B ^a,b   Chuk, Lai man R ^a,b   Nissen, Michael D ^a,b   Nolan, Terry M ^c,d   Mcvernon, Jodie ^c,d   Booy, Robert ^e,f   Heron, Leon ^e,f   Richmond, Peter C ^g,h   Walls, Tony ^i,j   Marshall, Helen S ^k,l   Reynolds, Graham J ^m,n   Hartel, Gunter F ^o   Hu, Wilson ^o   Lai, Michael H ^o  

^a LADY CILENTO CHILDREN S HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^f UNIVERSITY OF SYDNEY   (Australia)

^g UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^h UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

ⁱ UNIVERSITY OF NEW SOUTH WALES   (Australia)

^j SYDNEY CHILDREN'S HOSPITAL   (Australia)

^k UNIVERSITY OF ADELAIDE   (Australia)

^l WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^m The Australian National University   (Australia)

ⁿ CANBERRA HOSPITAL   (Australia)

^o CSL LIMITED   (Australia)

more..

Author keywords

Adverse events; Fever; Influenza vaccine; Paediatrics; Safety

Indexed keywords

ANTIPYRETIC AGENT; IBUPROFEN; INFLUENZA VACCINE; ORAL REHYDRATION SOLUTION; PARACETAMOL;

ADOLESCENT; ADULT; ANOREXIA; ARTICLE; AXILLA TEMPERATURE; CHILD; DIARRHEA; DRUG FORMULATION; DRUG SAFETY; DRUG TOLERABILITY; FEBRILE CONVULSION; FEMALE; FEVER; FLU LIKE SYNDROME; HEADACHE; HUMAN; HUMAN EXPERIMENT; INFLUENZA; INFLUENZA VACCINATION; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; INJECTION SITE SWELLING; IRRITABILITY; MALAISE; MALE; MOUTH TEMPERATURE; MULTICENTER STUDY; MYALGIA; NAUSEA AND VOMITING; NORMAL HUMAN; ORAL REHYDRATION THERAPY; PHASE 4 CLINICAL TRIAL; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SIDE EFFECT; URTICARIA; VIRION;

ADVERSE EVENTS; FEVER; INFLUENZA VACCINE; PAEDIATRICS; SAFETY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DRUG TOLERANCE; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; FEVER; HUMANS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; PROSPECTIVE STUDIES; VACCINATION; VACCINES, INACTIVATED;

EID: 84882717451     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/irv.12107     Document Type: Article

References (29)

1. Lambert S, O'Grady KA, Gabriel S, Carter R, Nolan T. The cost of seasonal respiratory illnesses in Australian children: the dominance of patient and family costs and implications for vaccine use. Commun Dis Intell 2004; 28:510-516.
2. Iskander M, Booy R, Lambert S. The burden of influenza in children. Curr Opin Infect Dis 2007; 20:259-263.
3. Lambert SB, Allen KM, Carter RC, Nolan TM. The cost of community-managed viral respiratory illnesses in a cohort of healthy preschool-aged children. Respir Res 2008; 9:11.
4. Hoen AG, Buckeridge DL, Charland KML, Mandl KD, Quach C, Brownstein JS. Effect of expanded US recommendations for seasonal influenza vaccination: comparison of two pediatric emergency departments in the United States and Canada. CMAJ 2011; 183:E1025-E1032.
5. Hoberman A, Greenberg DP, Paradise JL. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial. JAMA 2003; 290:1608-1616.
6. Jansen AG, Sanders EA, Hoes AW, van Loon AM, Hak E. Effects of influenza plus pneumococcal conjugate vaccination versus influenza vaccination alone in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled trial. J Pediatr 2008; 153:764-770.
7. Monto AS, Davenport FM, Napier JA, Francis T Jr. Modification of an outbreak of influenza in Tecumseh, Michigan by vaccination of schoolchildren. J Infect Dis 1970; 122:16-25.
8. Hurwitz ES, Haber M, Chang A. Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts. JAMA 2000; 284:1677-1682.
9. Reichert TA, Sugaya N, Fedson DS, Glezen WP, Simonsen L, Tashiro M. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 2001; 344:889-896.
10. Piedra PA, Gaglani MJ, Kozinetz CA. Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children. Vaccine 2005; 23:1540-1548.
11. Ghendon YZ, Kaira AN, Elshina GA. The effect of mass influenza immunization in children on the morbidity of the unvaccinated elderly. Epidemiol Infect 2006; 134:71-78.
12. Davis MM, King JC Jr, Moag L, Cummings G, Magder LS. Countywide school-based influenza immunization: direct and indirect impact on student absenteeism. Pediatrics 2008; 122:e260-e265.
13. Kwong JC, Stukel TA, Lim J. The effect of universal influenza immunization on mortality and health care use. PLoS Med 2008; 5:e211.
14. Centers for Disease Control and Prevention. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010; 59:1-62.
15. Kelly H, Jacoby P, Dixon GA. Vaccine effectiveness against laboratory-confirmed influenza in healthy young children: a case-control study. Pediatr Infect Dis J 2011; 30:107-111.
16. Letter to General Practitioners - Update on Pandemic (H1N1) 2009 Influenza Vaccination. 2010. Available at http://www.flupandemic.gov.au/internet/panflu/publishing.nsf/Content/cmo-2010#12feb (Accessed 12 December 2012)
17. Jefferson T, Rivetti A, Harnden A, Di Pietrantonj C, Demicheli V. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev 2008; 8:CD004879.
18. Nolan T, Richmond PC, McVernon J. Safety and immunogenicity of an inactivated thimerosal-free influenza vaccine in infants and children. Influenza Other Respi Viruses 2009; 3:315-325.
19. A study to determine the immunogenicity and safety profile of CSL Limited's influenza virus vaccine compared to a US licensed comparator influenza virus vaccine in a pediatric population. Available at http://clinicaltrials.gov/ct2/show/results/NCT00959049 (Accessed 12 December 2012).
20. Whiley DM, Bialasiewicz S, Bletchly C. Detection of novel influenza A(H1N1) virus by real-time RT-PCR. J Clin Virol 2009; 45:203-204.
21. Appuhamy RD, Beard FH, Phung HN, Selvey CE, Birrell FA, Culleton TH. The changing phases of pandemic (H1N1) 2009 in Queensland: an overview of public health actions and epidemiology. Med J Aust 2010; 192:94-97.
22. Armstong PK, Dowse GK, Effler PV. Epidemiological study of severe febrile reactions in young children in Western Australia caused by a 2010 trivalent inactivated influenza vaccine. BMJ Open 2011; e000016.
23. Clinical advice for immunisation providers on resumption of the use of 2010 trivalent seasonal vaccines in children less than 5 years of age, July 2010. 2010. Available at http://www.health.gov.au/internet/immunise/Publishing.nsf/content/immunise-atagi-statement-tiv (Accessed 12 December 2012).
24. Nolan T, McVernon J, Skeljo M. Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial. JAMA 2010; 303:37-46.
25. A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in a Healthy Pediatric Population in the USA. Available at http://clinicaltrials.gov/ct2/show/results/NCT00958243 (Accessed 12 December 2012).
26. Overview of vaccine regulation and safety monitoring and investigation into adverse events following 2010 seasonal influenza vaccination in young children. Attachment E: TGA influenza seasonal trivalent influenza vaccine laboratory investigation program. Available at http://www.tga.gov.au/safety/alerts-medicine-seasonal-flu-101008-atte.htm (Accessed 12 December 2012).
27. Kelly HA, Skowronski DM, De Serres G, Effler PV. Adverse events associated with 2010 CSL and other inactivated influenza vaccines. Med J Aust 2011; 195:318-320.
28. Blyth CC, Currie AJ, Wiertsema SP. Trivalent influenza vaccine and febrile adverse events in Australia, 2010: clinical features and potential mechanisms. Vaccine 2011; 29:5107-5113.
29. Maraskovsky E, Rockman S, Dyson A. Scientific investigations into febrile reactions observed in the paediatric population following vaccination with a 2010 Southern Hemisphere Trivalent Influenza Vaccine. Vaccine 2012; 30:7400-7406.